GIF regulation of B cells and CD4 cells
GIF 对 B 细胞和 CD4 细胞的调节
基本信息
- 批准号:7173448
- 负责人:
- 金额:$ 31.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-02-01 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAntibodiesAntibody FormationAntigen PresentationAntigen-Presenting CellsAntigensAsthmaB-Cell ActivationB-LymphocytesBindingBiologicalBiological AssayBone MarrowCD4 Positive T LymphocytesCell Surface ProteinsCell divisionCellsChemicalsChimera organismCloningCollaborationsComplementary DNACysteineCytokine ReceptorsCytoplasmCytosolEndosomesEnzyme-Linked Immunosorbent AssayEventFacility Construction Funding CategoryFlow CytometryGene TargetingGenerationsHematopoieticImmune responseImmunizationIn VitroInfectionInflammationInterleukin-4KnowledgeLeishmania majorLysosomesMass Spectrum AnalysisMeasurementMeasuresMediatingMessenger RNAMigration Inhibitory FactorModificationMusOvumPhenotypePhosphorylationPost-Translational Protein ProcessingProcessProductionProtein Sequence AnalysisProteinsReceptors, Antigen, B-CellRegulationReportingRestRoleSamplingSomatic CellSourceT-Cell ActivationT-Independent AntigensT-LymphocyteTestingTimeTissuesWorkallergic airway inflammationaluminum sulfatecDNA Librarycell mediated immune responsecell typecrosslinkcytokinedisulfide bondexpression cloningglycosylation inhibiting factorin vivomouse modelphenylpyruvate tautomeraseprogramsreceptorreceptor expressionresearch studyresponsetraffickingtranscription factoruptake
项目摘要
DESCRIPTION (provided by applicant): The function of a cytokine called GIF or MIF has been unclear for a long time. However, recent studies have demonstrated that a posttranslational modification of this cytokine at C60 is required for the binding to the receptor and for the capability to inhibit B cell Ig switch, BCR-mediated antigen uptake, and IL-4 secretion from CD4 cells. GIF-/- mice displayed enhanced antibody responses to a T-dependent antigen regardless of Ig isotype but normal responses to a T-independent antigen. CD4 cells from GIF-/- mice differentiated toward a Th2 phenotype as compared with wild type cells. GIF receptor was undetectable in resting mouse T and B cells, but after in vitro stimulation the receptor was induced on these cells. GIF receptor appeared to be a 50-52 kDa cell surface protein. To determine whether the biological effects of GIF is mediated through the interaction of GIF and its receptor, anti-receptor mAb will be generated and the cDNA encoding the receptor will be cloned. To define the target cells for this cytokine, the expression of the receptor will be delineated using cells and mRNA samples from various hematopoietic and nonhematopoietic tissues. To clarify the role of GIF in regulating B cell activation in T-B collaboration, HEL-specific B cells from MD4 BCR Tg mice and Ova-specific CD4 cells from DO11.10 TCR Tg mice, either on GIF+/+ or -/- background, will be stimulated in vitro with HEL-Ova conjugate. The secretion of GIF, the induction of its receptor, and the events associated with B cell activation will be analyzed in the course of the cognate T-B interaction. The effects of GIF on BCR-dependent antigen uptake, trafficking, and processing will be analyzed. To determine the role of GIF on cytokine production and Th differentiation of CD4 cells, the expression of GIF receptor and the secretion of GIF upon T cell activation will be analyzed. The source of GIF that regulates Th differentiation will be determined by adoptive transfer experiments using CD4 cells from GIF+/+ and -/- DO11.10 TCR Tg mice and bone marrow chimera constructions. The mechanism by which GIF inhibits Th2 differentiation and/or induces Th1 differentiation will be analyzed with regard to Stat phosphorylation and transcription factors. The role of GIF in regulating Th2-type inflammation will be evaluated in the mouse model of antigen-induced bronchial asthma. These experiments will establish the role of this cytokine in CD4 T cell-mediated immune responses.
描述(由申请人提供):一种称为GIF或MIF的细胞因子的功能长期以来一直不清楚。然而,最近的研究表明,该细胞因子需要在C60处进行翻译后修饰才能与受体结合,并能够抑制B细胞Ig开关、bcr介导的抗原摄取和CD4细胞分泌IL-4。GIF-/-小鼠对t依赖性抗原表现出增强的抗体反应,与Ig同型无关,但对t非依赖性抗原表现出正常反应。与野生型细胞相比,来自GIF-/-小鼠的CD4细胞向Th2表型分化。静止小鼠T细胞和B细胞中检测不到GIF受体,但在体外刺激后,这些细胞被诱导出该受体。GIF受体是一个50-52 kDa的细胞表面蛋白。为了确定GIF的生物学效应是否通过GIF与其受体的相互作用介导,我们将生成抗受体mAb,并克隆编码受体的cDNA。为了确定这种细胞因子的靶细胞,受体的表达将使用来自各种造血和非造血组织的细胞和mRNA样本来描述。为了阐明GIF在T-B协同作用中调节B细胞活化的作用,我们在体外用HEL-Ova偶联物刺激GIF+/+或-/-背景下MD4 BCR Tg小鼠的hell特异性B细胞和DO11.10 TCR Tg小鼠的ova特异性CD4细胞。GIF的分泌、受体的诱导以及与B细胞活化相关的事件将在同源T-B相互作用的过程中进行分析。GIF对bcr依赖性抗原摄取、运输和加工的影响将被分析。为了确定GIF对CD4细胞细胞因子产生和Th分化的作用,我们将分析在T细胞活化时GIF受体的表达和GIF的分泌。通过采用来自GIF+/+和-/- DO11.10 TCR Tg小鼠的CD4细胞和骨髓嵌合体构建的过继性转移实验,确定调节Th分化的GIF来源。GIF抑制Th2分化和/或诱导Th1分化的机制将根据Stat磷酸化和转录因子进行分析。我们将在小鼠抗原诱导支气管哮喘模型中评估GIF对th2型炎症的调节作用。这些实验将确定这种细胞因子在CD4 T细胞介导的免疫应答中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATSUJI SUGIE其他文献
KATSUJI SUGIE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATSUJI SUGIE', 18)}}的其他基金
GIF regulation of B cells and CD4 cells
GIF 对 B 细胞和 CD4 细胞的调节
- 批准号:
7340680 - 财政年份:2004
- 资助金额:
$ 31.49万 - 项目类别:
GIF regulation of B cells and CD4 cells
GIF 对 B 细胞和 CD4 细胞的调节
- 批准号:
7008888 - 财政年份:2004
- 资助金额:
$ 31.49万 - 项目类别:
GIF regulation of B cells and CD4 cells
GIF 对 B 细胞和 CD4 细胞的调节
- 批准号:
6847820 - 财政年份:2004
- 资助金额:
$ 31.49万 - 项目类别:
GIF regulation of B cells and CD4 cells
GIF 对 B 细胞和 CD4 细胞的调节
- 批准号:
6777928 - 财政年份:2004
- 资助金额:
$ 31.49万 - 项目类别:
GIF regulation of B cells and CD4 cells
GIF 对 B 细胞和 CD4 细胞的调节
- 批准号:
6674735 - 财政年份:2003
- 资助金额:
$ 31.49万 - 项目类别:
GIF regulation of CD4 T-dependent immune responses
GIF 调节 CD4 T 依赖性免疫反应
- 批准号:
6333331 - 财政年份:2001
- 资助金额:
$ 31.49万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 31.49万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 31.49万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 31.49万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 31.49万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 31.49万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 31.49万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 31.49万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 31.49万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 31.49万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 31.49万 - 项目类别:














{{item.name}}会员




